THE SIGNIFICANCE OF SUBNORMAL SERUM VITAMIN-B-12 CONCENTRATION IN OLDER-PEOPLE - A CASE-CONTROL STUDY

Citation
J. Metz et al., THE SIGNIFICANCE OF SUBNORMAL SERUM VITAMIN-B-12 CONCENTRATION IN OLDER-PEOPLE - A CASE-CONTROL STUDY, Journal of the American Geriatrics Society, 44(11), 1996, pp. 1355-1361
Citations number
20
Categorie Soggetti
Geiatric & Gerontology","Geiatric & Gerontology
ISSN journal
00028614
Volume
44
Issue
11
Year of publication
1996
Pages
1355 - 1361
Database
ISI
SICI code
0002-8614(1996)44:11<1355:TSOSSV>2.0.ZU;2-L
Abstract
OBJECTIVES: To determine the clinical significance of subnormal serum vitamin B-12 concentration in older people by comparing the hematologi cal, neurological, and biochemical findings in patients with subnormal serum B-12 with a control group with normal B-12 levels. DESIGN: Clin ical and laboratory assessment of hospital patients selected to repres ent a wide range of serum B-12 levels. SETTING: Patients in the medica l wards of two hospitals, one a general hospital and the other a geria tric hospital. PARTICIPANTS: Ninety-four older patients, 43 with subno rmal (<150 pmol/L) and 51 with normal serum homocysteine were signific antly different in the low serum B-12 compared with the control group. There was a significant correlation between serum B-12 and homocystei ne levels. Eighty-eight percent of patients in the test group compared with 76% in the control group showed at least one of the following; e levated serum total homocysteine, neutrophil hypersegmentation, or ele vated MCV. This overlap was much reduced when patients with borderline values for serum B-12 (150-250 pmol/L) were included in the low B-12 group. Most of the older subjects had little or no B-12 on transcobala min II, irrespective of the serum B-12 level. CONCLUSION: Almost 90% o f older patients with serum B-12 < 150 pmol/L show evidence of tissue vitamin B-12 deficiency. Deficiency becomes manifest in older patients at relatively higher concentrations of serum B-12 than in younger sub jects, possibly because of lower levels of holotranscobalamin II in th e older patients.